Company Overview
- Headquarters
- 11 Hurley St, Cambridge MA
- Website
- editasmedicine.com
- in****@editasmedicine.com
- Phone
- (617) 401-****
- Employees
- 341
- Founded in
- 2013
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:EDI
- NAICS Code
- 54, 5417, 32, 541, 325, 541714, 54171
- SIC Code
- 28, 8731, 87, 2834, 873, 283
Financials & Stats
Revenue
$20B
Total Funding Amount
$257M
Who is Editas Medicine
Editas Medicine is a clinical stage genome editing company headquartered in Cambridge, Massachusetts. The company has 266 employees and generates approximately $100 million in annual revenue. Editas Medicine is dedicated to developing transformative genomic medicines using CRISPR/Cas9 and CRISPR/Cas12a genome editing systems. Their goal is to create durable, precise treatments for a wide range of serious diseases. The company distinguishes itself through its team of expert "Editors" and its unique culture focused on collaboration and innovation. Editas Medicine believes in the power of genome editing technology to revolutionize medicine and is committed to making a positive impact on patients worldwide. To learn more about Editas Medicine's groundbreaking research and career opportunities, visit their website at editasmedicine.com.
Company Leadership
Editas Medicine Industry Tags
Editas Medicine Tech Stack
Companies Similar to Editas Medicine
Analyze industry trends and opportunities by examining competitors and companies comparable to Editas Medicine, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 20M | 46 | Irving, TX | 1972 | |
| 19M | 506 | Research Triangle Park, NC | 2001 | |
| 19M | Valatie, NY | |||
| 19M | 28 | Gardner, MA | 1998 | |
| 19M | 34 | Waltham, MA | 2012 |